Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Neuropharmacology
|
June 18, 2013
NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test
Snjezana Lelas, Yu-Wen Li, Tanya L Wallace-Boone, et al.
Journal of Medicinal Chemistry
|
October 29, 2004
Synthesis, structure-activity relationships, and in vivo properties of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as corticotropin-releasing factor-1 receptor antagonists
Carolyn D Dzierba, Amy G Takvorian, Maria Rafalski, et al.
Neuropharmacology
|
November 3, 2015
Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy
Yu-Wen Li, Matthew A Seager, Trevor Wojcik, et al.
Pharmacology, Biochemistry, and Behavior
|
September 16, 2017
Characterization of the adrenocorticotrophic hormone - induced mouse model of resistance to antidepressant drug treatment
Bettadapura N Srikumar, Mahesh Paschapur, Narasimharaju Kalidindi, et al.
Nuclear Medicine and Biology
|
May 6, 2014
Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors
Nicholas J Lodge, Yu-Wen Li, Frederick T Chin, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 7, 2015
Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitors
Andrew P Degnan, George O Tora, Ying Han, et al.
Journal of Psychopharmacology (Oxford, England)
|
November 29, 2018
Diminished responses to monoaminergic antidepressants but not ketamine in a mouse model for neuropsychiatric lupus
Bettadapura N Srikumar, Pattipati S Naidu, Narasimharaju Kalidindi, et al.
Journal of Medicinal Chemistry
|
April 14, 2009
8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists
Paul J Gilligan, Liqi He, Todd Clarke, et al.
Journal of Medicinal Chemistry
|
April 14, 2009
Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists
Paul J Gilligan, Todd Clarke, Liqi He, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 21, 2012
Design, optimization, and in vivo evaluation of a series of pyridine derivatives with dual NK1 antagonism and SERT inhibition for the treatment of depression
Kevin W Gillman, Michael F Parker, Mark Silva, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Neuropharmacology
|
June 18, 2013
NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test
Snjezana Lelas, Yu-Wen Li, Tanya L Wallace-Boone, et al.
Journal of Medicinal Chemistry
|
October 29, 2004
Synthesis, structure-activity relationships, and in vivo properties of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as corticotropin-releasing factor-1 receptor antagonists
Carolyn D Dzierba, Amy G Takvorian, Maria Rafalski, et al.
Neuropharmacology
|
November 3, 2015
Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy
Yu-Wen Li, Matthew A Seager, Trevor Wojcik, et al.
Pharmacology, Biochemistry, and Behavior
|
September 16, 2017
Characterization of the adrenocorticotrophic hormone - induced mouse model of resistance to antidepressant drug treatment
Bettadapura N Srikumar, Mahesh Paschapur, Narasimharaju Kalidindi, et al.
Nuclear Medicine and Biology
|
May 6, 2014
Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors
Nicholas J Lodge, Yu-Wen Li, Frederick T Chin, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 7, 2015
Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitors
Andrew P Degnan, George O Tora, Ying Han, et al.
Journal of Psychopharmacology (Oxford, England)
|
November 29, 2018
Diminished responses to monoaminergic antidepressants but not ketamine in a mouse model for neuropsychiatric lupus
Bettadapura N Srikumar, Pattipati S Naidu, Narasimharaju Kalidindi, et al.
Journal of Medicinal Chemistry
|
April 14, 2009
8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists
Paul J Gilligan, Liqi He, Todd Clarke, et al.
Journal of Medicinal Chemistry
|
April 14, 2009
Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists
Paul J Gilligan, Todd Clarke, Liqi He, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 21, 2012
Design, optimization, and in vivo evaluation of a series of pyridine derivatives with dual NK1 antagonism and SERT inhibition for the treatment of depression
Kevin W Gillman, Michael F Parker, Mark Silva, et al.
Page
of 8